Effectiveness of curcumin in endometriosis.
Not Applicable
- Conditions
- Endometriosis.Endometriosis
- Registration Number
- IRCT20221111056469N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 86
Inclusion Criteria
Women aged 18 to 45 years experiencing pain associated with endometriosis proven by ultrasound and examination and history
No previous history of using hormonal agents
Candidate to receive dinogest
Exclusion Criteria
Pregnancy or breastfeeding
Amenorrhea
The need for surgery after the intervention
Previous use of hormonal agents (such as GnRH agonists for 6 months, progestins, dienogest or danazol for 3 months or oral contraceptives for 1 month before the intervention)
Abnormal findings in women's examination
Abnormal cervical cytology smear in the last 3 months
Taking narcotic painkillers before surgery on a daily basis for 2 weeks before surgery
Additional surgeries performed or malignancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score Of The Quality of life questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and 2 months later. Method of measurement: Specific Questionnaire of Quality of Life in Endometriosis Patient(Endometriosis Health Profile-30).;Sexual performance score in the questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and 2 months later. Method of measurement: Female Sexual Function index.;Endometrioma lesion Size. Timepoint: At the beginning of the study (before the start of the intervention) and 2 months later. Method of measurement: Ultrasound and Medical Examination.;Pain Score in the Questionnaire. Timepoint: At the beginning of the study (before the intervention) and 2 months later. Method of measurement: Pain Visual Analog Scale Questionnaire.
- Secondary Outcome Measures
Name Time Method Pain Score in the Questionnaire. Timepoint: At the beginning of the study (before the intervention) and 2 months later. Method of measurement: Pain Visual Analog Scale Questionnaire.;Sexual performance score in the questionnaire. Timepoint: At the beginning of the study (before the intervention) and 2 months later. Method of measurement: Female Sexual Function Index.;Quality of life score in the questionnaire. Timepoint: At the beginning of the study (before the intervention) and 2 months later. Method of measurement: Specific Questionnaire of Quality of life in Endometriosis Patient(Endometriosis Health Profile-30).;Endometrioma lesion size. Timepoint: At the beginning of the study (before the intervention) and 2 months later. Method of measurement: Ultrasound and medical examination.